Literature DB >> 3169111

Renal function and blood pressure in patients treated with cyclosporin A for uveitis.

G Deray1, P Le Hoang, P Cacoub, B Aupetit, A Mertani, F Martinez, J Rottembourg.   

Abstract

Renal function has been evaluated in 21 patients treated with cyclosporin A (CyA) for 9 months for idiopathic uveitis. Serum creatinine, which was 82 mumol.l-1 before treatment, was significantly elevated after 1 month (111 mumol.l-1). After 9 months of treatment, and despite a decrease in CyA dosage, the mean plasma creatinine remained elevated at 132 mumol.l-1. Hypertension developed in 6 patients, five of them being concomitantly treated with corticosteroids. In 8 patients serum creatinine 3 months after CyA had been stopped had decreased from 148 to 93 mumol.l-1. Two of those patients remained hypertensive 3 months after CyA treatment had ceased. In patients with idiopathic uveitis CyA induces a reversible increase in serum creatinine. However the reversibility of such a biochemical marker does not preclude a histopathological lesion. Chronic renal damage may be responsible for the persistence of hypertension after cessation of CyA treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169111     DOI: 10.1007/bf00615224

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

Review 1.  Cyclosporine: a new immunosuppressive agent for organ transplantation.

Authors:  D J Cohen; R Loertscher; M F Rubin; N L Tilney; C B Carpenter; T B Strom
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

2.  Side effects of cyclosporin A treatment in patients with rheumatoid arthritis.

Authors:  K J Berg; O Førre; F Bjerkhoel; E Amundsen; O Djøseland; H E Rugstad; B Westre
Journal:  Kidney Int       Date:  1986-06       Impact factor: 10.612

3.  Side effects of systemic cyclosporine in patients not undergoing transplantation.

Authors:  A G Palestine; R B Nussenblatt; C C Chan
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

4.  Cyclosporin A in patients receiving renal allografts from cadaver donors.

Authors:  R Y Calne; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; B D Pentlow; K Rolles
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

5.  Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

Authors:  A G Palestine; H A Austin; J E Balow; T T Antonovych; S G Sabnis; H G Preuss; R B Nussenblatt
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

6.  A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245

7.  Renal function and blood pressure in heart transplant recipients treated with cyclosporine.

Authors:  J Rottembourg; M F Mattei; A Cabrol; P Leger; B Aupetit; H Beaufils; J C Gluckman; A Pavie; I Gandjbakhch; C Cabrol
Journal:  J Heart Transplant       Date:  1985 Jul-Aug
  7 in total
  1 in total

Review 1.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.